KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Shares Outstanding (Weighted Average) (2016 - 2025)

Merck (MRK) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $2.5 billion as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) fell 1.18% to $2.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Dec 2025, down 1.18% year-over-year, with the annual reading at $2.5 billion for FY2025, 1.18% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $2.5 billion at Merck, roughly flat from $2.5 billion in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $2.5 billion in Q2 2023, with the low at $2.5 billion in Q4 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $2.5 billion, with a median of $2.5 billion recorded in 2021.
  • The sharpest move saw Shares Outstanding (Weighted Average) increased 0.4% in 2023, then dropped 1.18% in 2025.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $2.5 billion in 2021, then increased by 0.08% to $2.5 billion in 2022, then increased by 0.2% to $2.5 billion in 2023, then fell by 0.2% to $2.5 billion in 2024, then fell by 1.18% to $2.5 billion in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $2.5 billion, $2.5 billion, and $2.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.